IFNB1 and neoplasm: As observed ex vivo in the tissue slice experiments, the combination of IFN-β plus gemcitabine significantly reduced the proportion of Ki-67 positive cells with 44%, while apoptosis was increased with 168% in tumor tissues compared with control group (both P < 0.05) (Fig. 6c and d).